OpGen
CapForce Inc. is a U.S. reporting company (SEC CIK 0001293818) that provides listing sponsorship and capital markets advisory services and is developing a digital investment banking platform supporting cross-border securities trading, investment banking advisory, asset management and cap table management. The group operates via subsidiaries in Labuan/Malaysia, Singapore and the British Virgin Islands and conducts platform brokerage through a partner investment bank under that partner’s license. The company’s common stock is quoted on the OTC Markets under the symbol CFOR.
Industries
Nr. of Employees
medium (51-250)
Patents
Systems, apparatus, and methods for generating and analyzing resistome profiles
US-10475526-B2
View Details
Systems, apparatus, and methods for generating and analyzing resistome profiles
US-10475526-B2
View DetailsProducts
CapForce EC platform
An offshore electronic securities trading platform developed and operated by the company’s Labuan-incorporated subsidiary in collaboration with a Labuan-licensed investment bank.
iCapX cap table management platform
A cap table and private equity dataset platform acquired and being refined to provide equity management and proprietary structured datasets for private companies.
Unyvero
Comprehensive testing panel and multiplex PCR system that accurately detects clinically relevant pathogens and antibiotic resistance markers associated with pneumonia directly from native specimens.
Gram-Negative QuickFISH BC
A multicolor, qualitative nucleic acid hybridization assay intended for the rapid identification of Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae on smears from positive blood cultures containing Gram-negative bacilli.
Staphylococcus QuickFISH BC
A multicolor, qualitative nucleic acid hybridization assay intended for the rapid identification of Staphylococcus aureus and/or coagulase-negative staphylococci from positive blood cultures.
GNR Traffic Light PNA FISH Culture Identification Kit
A multicolor, qualitative nucleic acid hybridization assay intended for the identification of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa on smears from positive blood cultures containing Gram-negative rods.
CapForce EC platform
An offshore electronic securities trading platform developed and operated by the company’s Labuan-incorporated subsidiary in collaboration with a Labuan-licensed investment bank.
iCapX cap table management platform
A cap table and private equity dataset platform acquired and being refined to provide equity management and proprietary structured datasets for private companies.
Unyvero
Comprehensive testing panel and multiplex PCR system that accurately detects clinically relevant pathogens and antibiotic resistance markers associated with pneumonia directly from native specimens.
Gram-Negative QuickFISH BC
A multicolor, qualitative nucleic acid hybridization assay intended for the rapid identification of Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae on smears from positive blood cultures containing Gram-negative bacilli.
Staphylococcus QuickFISH BC
A multicolor, qualitative nucleic acid hybridization assay intended for the rapid identification of Staphylococcus aureus and/or coagulase-negative staphylococci from positive blood cultures.
GNR Traffic Light PNA FISH Culture Identification Kit
A multicolor, qualitative nucleic acid hybridization assay intended for the identification of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa on smears from positive blood cultures containing Gram-negative rods.
Services
Consultancy and sponsorship services to support private companies through the process of listing on U.S. public markets, including transaction structuring, compliance and market readiness.
Cap table management services together with structured datasets of private company equity information to support due diligence and pricing accuracy.
Operation of an offshore electronic trading platform in collaboration with a Labuan-licensed investment bank; the company provides the financial technology platform while brokerage activity is executed under the partner bank’s license.
Consultancy and sponsorship services to support private companies through the process of listing on U.S. public markets, including transaction structuring, compliance and market readiness.
Cap table management services together with structured datasets of private company equity information to support due diligence and pricing accuracy.
Operation of an offshore electronic trading platform in collaboration with a Labuan-licensed investment bank; the company provides the financial technology platform while brokerage activity is executed under the partner bank’s license.
Expertise Areas
- Capital markets advisory and listing sponsorship
- Digital investment banking platform development
- Cross-border securities trading
- Cap table management and private company equity data
Key Technologies
- Digital investment banking platform
- Cross-border securities trading platform
- Cap table management systems
- Structured private company equity datasets
News & Updates
On 23 February 2026 stockholders approved an amendment to the certificate of incorporation changing the company name from OpGen, Inc. to CapForce Inc.; charter amendment filed in Delaware on 27 February 2026.
Press release furnished to the SEC announcing the company name change to CapForce Inc.
Annual report on Form 10-K as filed with the SEC.
On 23 February 2026 stockholders approved an amendment to the certificate of incorporation changing the company name from OpGen, Inc. to CapForce Inc.; charter amendment filed in Delaware on 27 February 2026.
Press release furnished to the SEC announcing the company name change to CapForce Inc.
Annual report on Form 10-K as filed with the SEC.